About Immuneering Corp. 
Immuneering Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 19 Schemes (25.09%)
Foreign Institutions
Held by 40 Foreign Institutions (7.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-12 Million
Pharmaceuticals & Biotechnology
USD 321 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.00
-27.41%
1.41






